Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
Int Arch Allergy Immunol. 2012;159(2):187-93. doi: 10.1159/000335926. Epub 2012 Jun 1.
Obesity is a risk factor for asthma in the general population, but the effect of obesity on airway hyperresponsiveness (AFHR) or airway inflammation in asthma is not clear. This study evaluated the relationship between obesity and asthma, assessing aspects of symptoms, AHR, and severity.
In total, 852 patients with asthma diagnosed by asthma specialists based on AHR as confirmed by a methacholine bronchial provocation test, were enrolled from the Cohort for Reality and Evolution of Adult Asthma in Korea (COREA) adult asthma cohort. The intensity of AHR was assessed by the concentration of methacholine needed to cause a 20% decrease in FEV(1) (PC(20)). Patients were classified into four categories based on body mass index (BMI): underweight (<18.5), normal weight (18.5-24.9), overweight (25.0-29.9), and obese (≥30).
BMI was negatively correlated with FEV(1) (l), FVC (l), and FEV(1)/FVC (%) in lung function tests. The prevalence of wheezing increased with higher BMI after adjustment for age, sex, smoking, medication history, and PC(20) (p < 0.0001). logPC(20) was lower in the normal weight group compared with the overweight group (p = 0.003). The risk of moderate or severe AHR (PC(20) ≤ 4 mg/ml) decreased with increased BMI after adjustment for age, sex, smoking, and medication history (p = 0.035).
Obesity is a risk factor for asthma in the general population, but obesity in asthmatic patients is negatively correlated with the intensity of AHR and is not related to asthma severity. Obesity is positively related with the prevalence of wheezing but negatively related to AHR in asthmatic patients.
肥胖是一般人群中哮喘的一个危险因素,但肥胖对哮喘患者气道高反应性(AHR)或气道炎症的影响尚不清楚。本研究评估了肥胖与哮喘之间的关系,评估了症状、AHR 和严重程度等方面。
共纳入 852 例由哮喘专家根据气道高反应性诊断的哮喘患者,这些患者通过乙酰甲胆碱支气管激发试验证实存在气道高反应性,来自韩国成人哮喘现实与演变队列研究(COREA)成人哮喘队列。AHR 的强度通过引起 FEV1 下降 20%的乙酰甲胆碱浓度(PC20)来评估。根据体重指数(BMI)将患者分为四组:体重不足(<18.5)、正常体重(18.5-24.9)、超重(25.0-29.9)和肥胖(≥30)。
BMI 与肺功能检查中的 FEV1(l)、FVC(l)和 FEV1/FVC(%)呈负相关。在调整年龄、性别、吸烟、用药史和 PC20 后,BMI 越高,喘息的发生率越高(p<0.0001)。与超重组相比,正常体重组的 logPC20 较低(p=0.003)。调整年龄、性别、吸烟和用药史后,BMI 越高,发生中度或重度 AHR(PC20≤4mg/ml)的风险越低(p=0.035)。
肥胖是一般人群中哮喘的一个危险因素,但哮喘患者的肥胖与 AHR 的强度呈负相关,与哮喘严重程度无关。肥胖与哮喘患者喘息的发生率呈正相关,与 AHR 呈负相关。